Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats.
about
Gut Microbiota and Lifestyle Interventions in NAFLDAdministration of a probiotic can change drug pharmacokinetics: effect of E. coli Nissle 1917 on amidarone absorption in ratsProbiotic Ferulic Acid Esterase Active Lactobacillus fermentum NCIMB 5221 APA Microcapsules for Oral Delivery: Preparation and in Vitro CharacterizationIn case of obesity, longevity-related mechanisms lead to anti-inflammation.Functional foods-based diet as a novel dietary approach for management of type 2 diabetes and its complications: A reviewGlucose- and glycaemic factor-lowering effects of probiotics on diabetes: a meta-analysis of randomised placebo-controlled trials.Probucol release from novel multicompartmental microcapsules for the oral targeted delivery in type 2 diabetes.Effect of probiotic fermented milk (kefir) on glycemic control and lipid profile in type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial.Effect of probiotics and synbiotics on blood glucose: a systematic review and meta-analysis of controlled trials.Probiotics and their Effects on Metabolic Diseases: An Update.The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens.Probiotics and Nonalcoholic Fatty liver Disease.Intestinal microbiota and overweight.Probiotics--interactions with bile acids and impact on cholesterol metabolism.Role of probiotics in modulating glucose homeostasis: evidence from animal and human studies.Probiotics as beneficial agents in the management of diabetes mellitus: a systematic review.Gut microbiota and probiotics: Focus on diabetes mellitus.Butyrate reduces high-fat diet-induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice.The effect of a tertiary bile acid, taurocholic acid, on the morphology and physical characteristics of microencapsulated probucol: potential applications in diabetes: a characterization study.Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of Antidiabetics.Deoxycholic Acid as a Modifier of the Permeation of Gliclazide through the Blood Brain Barrier of a Rat.Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study.An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer.Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol.Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect.Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics.Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial.The role of the bile acid chenodeoxycholic acid in the targeted oral delivery of the anti-diabetic drug gliclazide, and its applications in type 1 diabetes.Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes.Effect of Lactobacillus casei on the Pharmacokinetics of Amiodarone in Male Wistar Rats.An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations
P2860
Q26749783-ABC08CE8-F70E-4B47-A497-D393DAF76573Q28539513-A1EE44F3-2CCE-448E-993C-6866EA249460Q29011203-93A7BF39-1F03-4D50-88F8-B3AB13EE41B4Q33689066-E4DBB774-D089-4F62-A3E6-9DE66C301D36Q33759552-A9A0464F-F049-4B87-9384-ED455ADF3397Q34514979-944F23B9-2F66-411C-856F-F2F461A63BE9Q35024360-6B32E9DA-4D92-49F1-A03C-1166FD1B2E3CQ35466851-5A1D6D82-C96F-4AEC-A78C-ACD98515C6BAQ36122235-094AECAB-B225-466A-8C9E-E6BFE50BA84DQ36622603-BE8CBA67-946C-4BD8-8B95-1EB874D9EDF8Q37403044-E669A3CF-0B81-40D9-902F-978D36B22673Q37708418-C6E50996-81FD-4E2A-86B5-DDF3AC8C3F6CQ37915058-754BF424-3216-4D93-9074-F56FE58CEC34Q38051231-13BF78D5-6AB2-46A1-94B9-BCE088B3BD1AQ38088745-696088F1-22C0-4B75-B80E-5CC1CA93E935Q38473701-A8F0BDB3-ED7F-44E0-B69C-BC6798F306FDQ38616155-3D3FD5DF-BA73-4526-A483-2D6FE10E7372Q38786112-181636EA-8712-4AAC-95E7-74AAF06520F3Q38846334-5733B951-365A-4D1B-8B25-5C38083D7C33Q39351329-EFB00886-39F3-44AB-BD7B-95BB381FEEAAQ40509847-861F1823-5190-4023-821B-D6A21C3D89AAQ42770089-4180DCED-C120-46B9-BEEA-EBE2F1E7CF28Q42935253-5F890401-4AB6-4F1F-9382-EDF07B07E4C2Q43808142-387BA368-AA4A-4FF6-BD2A-7FB4ABB469DEQ48005483-C7991D76-B7F2-449F-B214-8F4CBB0D50FDQ48089000-2666D1B0-EDAC-467B-943D-15D1AF419430Q48177243-8269CF92-C969-4F38-B208-EC50FA1C2AA9Q50224848-242F31E4-BE92-4707-B1CA-70083897C201Q51833733-F82DD235-8C6B-45A8-B2E2-D51C444C01B6Q53281341-54750D5D-AC3E-405A-9B2A-220ABA54FDC4Q54252506-6E784EC1-502C-4CD1-B226-C38346EDA9C5Q57148084-ECB51A3C-B9BC-46EF-AA37-A4B554D8F269
P2860
Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Probiotic treatment reduces bl ...... f gliclazide in diabetic rats.
@en
Probiotic treatment reduces bl ...... f gliclazide in diabetic rats.
@nl
type
label
Probiotic treatment reduces bl ...... f gliclazide in diabetic rats.
@en
Probiotic treatment reduces bl ...... f gliclazide in diabetic rats.
@nl
prefLabel
Probiotic treatment reduces bl ...... f gliclazide in diabetic rats.
@en
Probiotic treatment reduces bl ...... f gliclazide in diabetic rats.
@nl
P2093
P50
P356
P1476
Probiotic treatment reduces bl ...... f gliclazide in diabetic rats.
@en
P2093
Grant Butt
Ian G Tucker
J Paul Fawcett
P2860
P2888
P304
P356
10.1007/BF03191026
P577
2008-04-01T00:00:00Z